第692号委员会意见:妊娠期及产后急性发作重度高血压的紧急治疗
妊娠期、产时或产后出现急性发作的重度收缩压或舒张压升高需紧急降压治疗。应在确认重度高血压后30-60分钟内尽快给予一线药物以降低孕产妇卒中风险。静脉拉贝洛尔和肼屈嗪长期被视为一线药物,无静脉通路时可考虑口服即刻释放硝苯地平;若连续适当剂量一线药物无效,建议紧急咨询麻醉科、母胎医学或重症监护专科医生讨论二线干预。
要点
- 急性发作重度高血压需在确认后30-60分钟内尽快启动一线降压治疗。
- 静脉拉贝洛尔和肼屈嗪为传统一线药物,无静脉通路时可考虑口服即刻释放硝苯地平。
- 连续适当剂量一线药物无效时,建议紧急咨询专科医生讨论二线干预。
核心结论
- 对妊娠期或产后急性发作重度高血压患者应尽快在30-60分钟内给予一线降压药物,以降低孕产妇卒中风险。
研究设计与样本
- 美国妇产科医师学会(Obstet Gynecol)发布的第692号委员会意见。
主要发现
- 实施标准化、循证的子痫前期和子痫管理临床指南已被证实可降低不良母体结局的发生率。
关键数值与推荐
- 静脉拉贝洛尔和肼屈嗪长期被视为妊娠期及产后急性发作重度高血压的一线药物。
- 现有证据提示口服即刻释放硝苯地平也可考虑作为一线治疗,尤其在没有静脉通路时。
- 若静脉推注拉贝洛尔、肼屈嗪或口服即刻释放硝苯地平以连续适当剂量给药后仍不能缓解急性发作重度高血压,建议紧急咨询麻醉科、母胎医学专科或重症监护专科医生讨论二线干预。
临床怎么用
- 个人和机构应建立机制,在患者出现高血压急症时立即给予药物。
- 一线药物应在确认重度高血压后30-60分钟内尽快给药。
- 无静脉通路时可考虑口服即刻释放硝苯地平作为一线治疗。
- 一线药物连续适当剂量无效时,建议紧急咨询麻醉科、母胎医学或重症监护专科医生。
局限性
- 目前关于钙通道阻滞剂用于该临床指征的信息相对较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; severe diastolic hypertension; or both require urgent antihypertensive therapy. Introducing standardized, evidence-based clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to reduce the incidence of adverse maternal outcomes. Individuals and institutions should have mechanisms in place to initiate the prompt administration of medication when a patient presents with a hypertensive emergency. Treatment with first-line agents should be expeditious and occur as soon as possible within 30-60 minutes of confirmed severe hypertension to reduce the risk of maternal stroke. Intravenous labetalol and hydralazine have long been considered first-line medications for the management of acute-onset, severe hypertension in pregnant women and women in the postpartum period. Although relatively less information currently exists for the use of calcium channel blockers for this clinical indication, the available evidence suggests that immediate release oral nifedipine also may be considered as a first-line therapy, particularly when intravenous access is not available. In the rare circumstance that intravenous bolus labetalol, hydralazine, or immediate release oral nifedipine fails to relieve acute-onset, severe hypertension and is given in successive appropriate doses, emergent consultation with an anesthesiologist, maternal-fetal medicine subspecialist, or critical care subspecialist to discuss second-line intervention is recommended.
引用
- Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 2017. PMID: 28333820. doi:10.1097/AOG.0000000000002019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。